Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0F1OG
|
||||
Former ID |
DIB006300
|
||||
Drug Name |
Soluble ErbB3 theragnostics
|
||||
Synonyms |
Soluble ErbB3 theragnostics (cancer); SErbB3 theragnostics (cancer), TBIG; SHer theragnostics (cancer), TBIG;Soluble ErbB3 theragnostics (cancer), TBIG; Soluble Her theragnostics (cancer), TBIG; P85-sErbB3 (cancer), TBIG
|
||||
Indication | Cancer [ICD9: 140-229; ICD10:C00-C96] | Investigative | [543486] | ||
Company |
Tumor Biology Investment Group Inc
|
||||
Target and Pathway | |||||
Target(s) | Receptor protein-tyrosine kinase erbB-3 | Target Info | Inhibitor | [543486] | |
NetPath Pathway | TNFalpha Signaling Pathway | ||||
PANTHER Pathway | Cadherin signaling pathway | ||||
EGF receptor signaling pathway | |||||
Pathway Interaction Database | ErbB2/ErbB3 signaling events | ||||
ErbB receptor signaling network | |||||
a6b1 and a6b4 Integrin signaling | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.